Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

LH - Labcorp Holdings Inc.


Close
229.89
0.200   0.087%

Share volume: 488,578
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$229.69
0.20
0.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-0.12%
1 Month
8.24%
3 Months
19.22%
6 Months
9.16%
1 Year
9.16%
2 Year
9.16%
Key data
Stock price
$229.89
P/E Ratio 
42.94
DAY RANGE
$227.92 - $231.49
EPS 
$5.76
52 WEEK RANGE
$191.37 - $237.72
52 WEEK CHANGE
$0.09
MARKET CAP 
19.302 B
YIELD 
0.63%
SHARES OUTSTANDING 
83.963 M
DIVIDEND
$0.72
EX-DIVIDEND DATE
08/29/2024
NEXT EARNINGS DATE
10/31/2024
BETA 
0.33
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$358,623
AVERAGE 30 VOLUME 
$518,736
Company detail
CEO:
Region: US
Website: https://www.labcorp.com
Employees: 25,429
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.

Recent news